http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101911515-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-74 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
filingDate | 2013-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101911515-B1 |
titleOfInvention | Multi-transgenic cell line expressing immunological rejection inhibitory gene by α-Gal gene targeting knock-in vector and a manufacturing method thereof |
abstract | The present invention is based on the finding that genes capable of suppressing the stepwise immune rejection reaction that may occur at the time of heterologous transplantation are transfected with a complex transformed vector loaded with alpha-1,3-galactosyltransferase gene The present invention relates to a transgenic complex transformed cell line and a method for producing the same, and by confirming a multiple gene transfected cell line capable of regulating a series of immune rejection reactions occurring at the time of xenotransplantation, . ≪ / RTI > |
priorityDate | 2013-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 549.